Symbols / ACTU Stock $2.97 +17.39% Actuate Therapeutics, Inc. Common stock

Healthcare • Biotechnology • United States • NGM
ACTU (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Biotechnology
CEO Mr. Daniel M. Schmitt
Exch · Country NGM · United States
Market Cap 70.42M
Enterprise Value 57.26M
Income -22.23M
Sales —
FCF (ttm) -11.04M
Book/sh 0.34
Cash/sh 0.56
Employees 12
Insider 10d —
IPO Aug 13, 2024
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -3.50
PEG —
P/S —
P/B 8.71
P/C —
EV/EBITDA —
EV/Sales —
Quick Ratio 2.31
Current Ratio 2.39
Debt/Eq —
LT Debt/Eq —
EPS (ttm) -1.06
EPS next Y -0.85
EPS Growth —
Revenue Growth —
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-05-15
Earnings (prior) 2026-03-26
ROA -120.40%
ROE -5.54%
ROIC —
Gross Margin 0.00%
Oper. Margin 0.00%
Profit Margin 0.00%
Shs Outstand 23.71M
Shs Float 8.27M
Insider Own 15.50%
Instit Own 57.70%
Short Float 8.92%
Short Ratio 7.05
Short Interest 914.99K
52W High 11.99
vs 52W High -75.23%
52W Low 1.58
vs 52W Low 87.97%
Beta —
Impl. Vol. —
Rel Volume 2.42
Avg Volume 115.57K
Volume 279.71K
Target (mean) $13.50
Tgt Median $11.50
Tgt Low $6.00
Tgt High $25.00
# Analysts 4
Recom Strong_buy
Prev Close $2.53
Price $2.97
Change 17.39%
About

No company description available for this symbol.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
—
Latest analyst target
3. DCF / Fair value
$-8.38
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
—
Low
—
High
—
Mean
—
News
RSS: Latest ACTU news

No recent news from Yahoo. Try the RSS feed for latest ACTU news.

Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-02-13 SCHMITT DANIEL M. Chief Executive Officer — 272,055 — —
2026-01-05 THOMSON TODD S. Director and Beneficial Owner of more than 10% of a Class of Security — 280,000 $5.80 $1,624,000
2025-06-27 BIOS EQUITY COF, LP Beneficial Owner of more than 10% of a Class of Security — 71,428 $7.00 $499,996
2024-08-14 THOMSON TODD S. Director and Beneficial Owner of more than 10% of a Class of Security — 18,750 $8.00 $150,000
2024-08-14 THOMSON TODD S. Director and Beneficial Owner of more than 10% of a Class of Security — 2,605,776 — —
2024-08-14 BIOS EQUITY COF, LP Beneficial Owner of more than 10% of a Class of Security — 500,000 $8.00 $4,000,000
2024-08-14 BIOS EQUITY COF, LP Beneficial Owner of more than 10% of a Class of Security — 24,999 $8.00 $199,992
2024-08-14 BIOS EQUITY COF, LP Beneficial Owner of more than 10% of a Class of Security — 9,418,650 $5.27 $200,002
Financials

No financial statements available. Data is sourced from Yahoo Finance and cached; historical storage may be added later.

SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category